A total of 16 trials have compared the use of low-molecular-weight heparin (LMWH) to unfractionated heparin (UFH) in patients undergoing percutaneous coronary intervention (PCI). Although the rates of ...
Dec. 22, 2004 — The U.S. Food and Drug Administration (FDA) approved in October revisions to drug safety labeling to advise healthcare professionals of the following changes: use of the multidose ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback